Fintech

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

Prnewswire·April 2, 2026 at 12:15 PM

/PRNewswire/ -- CellCarta, a global provider of precision medicine laboratory services for drug development, and Pillar Biosciences, a leader in NGS-based...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

DOJ crypto memo author named interim AG
CoinDesk
Drift crypto exchange remains frozen after attack
PYMNTS
Amazon adds fuel surcharge for sellers
PYMNTS
DOJ Appeals Anthropic AI Ban Restoration
PYMNTS

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

DOJ crypto memo author named interim AG

Drift crypto exchange remains frozen after attack

Amazon adds fuel surcharge for sellers

DOJ Appeals Anthropic AI Ban Restoration